Dean Kereiakes and C. MIchael Gibson discuss a randomized trial of a novel, ultra-low-profile fixed-wire DES.

Robert Harrington and C. Michael Gibson discuss the registry's design, implementation, and initial results.

Ehrin Armstrong and C. Michael Gibson discuss a randomized, dose-escalation trial of temsirolimus adventitial delivery below the knee.

John Teerlink and C. Michael Gibson discuss omecamtiv mecarbil in chronic HFrEF.

Timothy Henry and C. Michael Gibson discuss outcomes from the North American registry.

Iacopo Olivotto and C. Michael Gibson discuss mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy.

C. Michael Gibson and Catalin Toma discuss acute hemodynamic improvement with percutaneous mechanical thrombectomy in a real-world pulmonary embolism population.

Burkert Pieske and C. Michael Gibson discuss sacubitril/valsartan versus individualized RAAS blockade in HFpEF.

Pierre-Marie Roy and C. Michael Gibson discuss hospitalization or outpatient management of PE.

Paulus Kirchhof and C. Michael Gibson discuss early rhythm control therapy in patients with atrial fibrillation.